Editorial label review
Alloy side effects: heart palpitations
Primary formulary: Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms
Quick answer
Heart palpitations shows up on the FDA labels for the active ingredients Alloy prescribes — Estradiol (oral and patch) + oral micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.
What Alloy prescribes and why it matters for heart palpitations
Alloy prescribes FDA-approved bioidentical estradiol and oral micronized progesterone, plus oxybutynin ER as a non-hormonal option for vasomotor symptoms. Because Alloy prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Palpitation-adjacent risk is anchored in the estradiol PIL boxed cardiovascular warning across all four brands.
Common label-level side effects
Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.
- Palpitations are listed at < 1% on estradiol PIL Section 6 adverse-reaction tables
- Estradiol PIL Section 5.1 carries the WHI-era boxed warning for cardiovascular events — palpitations should trigger review even when uncommon
- Fezolinetant (Veozah) PIL lists no palpitations signal but requires baseline hepatic monitoring
Serious label-level warnings
Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.
- Palpitations paired with chest pain, breathlessness, or fainting — call 911 per estradiol PIL Section 5.1 cardiovascular boxed warning
- Sustained irregular pulse — evaluate urgently for atrial fibrillation and thromboembolism risk
When to contact your clinician
Seek emergency care if palpitations are paired with chest pain, breathlessness, or fainting — the estradiol boxed warning treats these as possible MI or thromboembolism.
Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.
What to ask your provider
- “Which SKU in the Alloy formulary am I on, and what is its labelled frequency for heart palpitations?”
- “Is my heart palpitationslikely a labelled adverse reaction, or something separate that needs its own workup?”
- “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
- “What is the plan if heart palpitationsdoes not settle within 2–3 cycles?”
Related editorial reading
- Full editorial review of Alloy — formulary, pricing, and clinician model.
- Is heart palpitations caused by menopause itself? — how the transition presents on its own.
- Estradiol medication page — mechanism, dosing, and full PIL notes.
- Progesterone medication page — secondary ingredient in Alloy's formulary.
- Browse all side-effect matrix pages — 4 brands × 15 symptoms.
Frequently asked questions
- How often does heart palpitations happen on Alloy?
- Alloy's primary regimen — Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms — carries the FDA-labelled adverse-reaction frequencies for heart palpitations described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
- When should I stop Alloy because of heart palpitations?
- Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
- Is heart palpitations on the FDA label for Alloy's medications?
- Palpitation-adjacent risk is anchored in the estradiol PIL boxed cardiovascular warning across all four brands.
- Is heart palpitations caused by menopause itself?
- Heart palpitations can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/heart-palpitations explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.